Register | Login
World Pharma News .net


H. Lundbeck A/S (Lundbeck) today announced positive headline results from a dose finding clinical trial with the compound Lu AA24530 for the treatment of major depressive disorder (MDD).

Who Voted for this Story



Enter your email address:

Delivered by FeedBurner